Clinical Trial: USOR 21242

Trial Status: Open
Disease Type: Basket Trials
Trial ID USOR 21242
Sponsor ID CBP-21-0

A Phase 2 Multicenter, Randomized, Parallel Group Study to Establish the Efficacy and Safety of Combinations of CBP501, Cisplatin, and Nivolumab for > or = 3rd Line Treatment of Patients with Exocrine Pancreatic Cancer and WBC <10,000 at Screening

Principal Investigator
Keeran R. Sampat, MD
5 Locations

Locations

Fairfax Office

Arlington Office

Alexandria Office

Loudoun Office

Gainesville Office

Learn More About This Trial

Other Relevant Trials
Trial ID AVB500-PC-005
Sponsor ID Aravive, Inc

A Phase 1b/2 Randomized Study of AVB-S6-500 plus Nabpaclitaxel and Gemcitabine in Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Trial ID 18109
Sponsor ID

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis of FN (20170758)

Principal Investigator
Timothy A. McCarthy, MD
5 Locations